Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 4, 2013CirculationOpen Access

High-Density Lipoprotein Cholesterol, Size, Particle Number, and Residual Vascular Risk After Potent Statin Therapy

View Full Paper
Ask AI
Bookmark
Share

Authors

Samia Mora
Samia MoraGeneral / Preventive / Lipids
Robert J. Glynn
Robert J. GlynnPreventive Cardiology
Paul M. Ridker
Paul M. RidkerGeneral / Preventive / Lipids

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Mora et al. (2013) studied this question.

synapsesocial.com/papers/69f29ca41b51e2fbf0187178https://doi.org/10.1161/circulationaha.113.002671
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Effects of Torcetrapib in Patients at High Risk for Coronary Events2007 · 3,167 citations
  2. 2Rosuvastatin to Prevent Vascular Events in Men and Women With Elevated C-Reactive Protein2009 · 3,653 citations
  3. 3High-Density Lipoprotein Cholesterol and Particle Concentrations, Carotid Atherosclerosis, and Coronary Events2012 · 368 citations
  4. 4MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebocontrolled trial2002 · 7,042 citations